# A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

> **NCT00283218** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 24 (—)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** NovoRapid, NovoMix 30, Bifasisk Insulin Aspart 50, BIAsp70

## Key facts

- **NCT ID:** NCT00283218
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 24 (—)
- **Last updated:** 2006-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00283218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00283218, "A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00283218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*